Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DHDDS-related juvenile parkinsonism is caused by impaired lipid metabolism, glycosylation, and mitochondrial dysfunction, which can be rescued by NAD⁺ treatment.

medRxiv : the preprint server for health sciences·2026
Same author

Cardiac transplant outcomes in a pediatric patient with novel homozygous variants in TOP3Α causing mitochondrial dysfunction.

Molecular genetics and metabolism·2025
Same author

Are viral vector-mediated therapies compatible with aberrant glycosylation?

Molecular therapy. Methods & clinical development·2025
Same author

Corrigendum to 'Phosphodiesterase type 5 inhibition as a therapeutic strategy in primary mitochondrial disease: Evidence from patient fibroblasts and clinical observations' [Molecular Genetics and Metabolism Volume 146, Issues 1-2 (2025) Pages 109197].

Molecular genetics and metabolism·2025
Same author

Predicting disease-overarching therapeutic approaches for congenital disorders of glycosylation using multi-OMICS.

Molecular genetics and metabolism·2025
Same author

Predicting disease-overarching therapeutic approaches for Congenital Disorders of Glycosylation using multi-OMICS.

bioRxiv : the preprint server for biology·2025
Same journal

Pain in People Living With Obesity: Baseline Multidimensional Profiles, Prevalence and Biopsychosocial Factors From a Cohort Study.

European journal of pain (London, England)·2026
Same journal

Utility of Vibration Perception Thresholds as a Biomarker of Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis.

European journal of pain (London, England)·2026
Same journal

Efficacy of Low-Dose Naltrexone in Women With Fibromyalgia Syndrome: A 12-Month Randomised, Double-Blind, Placebo-Controlled Single-Centre Clinical Trial (INNOVA Study).

European journal of pain (London, England)·2026
Same journal

Short-Term Nociceptive Memory: Reduced Discriminability and Multiple Encoding Biases.

European journal of pain (London, England)·2026
Same journal

Predicting Pain: Electroencephalography Signatures of Neural Integration During Experimental Tonic Thermal Pain.

European journal of pain (London, England)·2026
Same journal

Assessing Chronic Pain Processes Longitudinally: Psychometric Evaluation of the German 'Assessing Chronic Pain Processes' (ProCEss) Item Set.

European journal of pain (London, England)·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats
08:07

Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats

Published on: August 24, 2016

Experimental neuropathy increases limbic forebrain CRF.

T Rouwette1, P Vanelderen, M de Reus

  • 1Department of Cellular Animal Physiology, Donders Institute for Brain, Cognition and Behaviour, Centre for Neuroscience, Radboud University Nijmegen, Nijmegen, The Netherlands. t.rouwette@science.ru.nl

European Journal of Pain (London, England)
|June 21, 2011
PubMed
Summary
This summary is machine-generated.

Neuropathic pain alters mood by affecting limbic system corticotropin-releasing factor (CRF), not the stress-response hypothalamo-pituitary-adrenal axis or Edinger-Westphal nucleus.

More Related Videos

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

Chronic Constriction Injury of the Rat's Infraorbital Nerve (IoN-CCI) to Study Trigeminal Neuropathic Pain
10:52

Chronic Constriction Injury of the Rat's Infraorbital Nerve (IoN-CCI) to Study Trigeminal Neuropathic Pain

Published on: September 21, 2015

Related Experiment Videos

Last Updated: May 31, 2026

Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats
08:07

Simultaneous Detection of c-Fos Activation from Mesolimbic and Mesocortical Dopamine Reward Sites Following Naive Sugar and Fat Ingestion in Rats

Published on: August 24, 2016

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

Chronic Constriction Injury of the Rat's Infraorbital Nerve (IoN-CCI) to Study Trigeminal Neuropathic Pain
10:52

Chronic Constriction Injury of the Rat's Infraorbital Nerve (IoN-CCI) to Study Trigeminal Neuropathic Pain

Published on: September 21, 2015

Area of Science:

  • Neuroscience
  • Pain Research
  • Mood Disorders

Background:

  • Neuropathic pain frequently co-occurs with stress, anxiety, and depression.
  • Corticotropin-releasing factor (CRF) is implicated, but its specific role in pain-related mood changes is unclear.

Purpose of the Study:

  • To investigate the neuronal basis of mood alterations in neuropathic pain.
  • To determine if neuropathic pain affects the hypothalamo-pituitary-adrenal (HPA) axis and Edinger-Westphal centrally projecting (EWcp) neurons.

Main Methods:

  • Induction of neuropathic pain via chronic constriction injury (CCI) of the rat sciatic nerve.
  • Measurement of Crf mRNA and CRF levels in specific brain regions (BSTov, CeA, PVN).
  • Assessment of urocortin 1 (Ucn1) mRNA and Ucn1, and immediate early gene products (cFos, deltaFosB) in EWcp neurons.

Main Results:

  • CCI significantly increased Crf mRNA and CRF in the BSTov and CeA.
  • No significant changes were observed in the PVN, HPA axis, or EWcp neurons regarding Ucn1 or immediate early gene expression.
  • Neuropathic pain did not alter Ucn1 or EWcp neuronal activity.

Conclusions:

  • Neuropathic pain-associated mood disturbances involve CRF in the limbic system.
  • Unlike acute stressors, neuropathic pain does not primarily engage the HPA axis or EWcp neurons.
  • The findings highlight distinct neural pathways for neuropathic pain-related mood changes versus acute stress responses.